ZCCHC18, also known as Zinc Finger CCHC-Type Containing 18, is a protein that plays a significant role in the regulation of RNA metabolism and processing within the cellular environment. This protein is characterized by its zinc finger domains, which are typically involved in binding to RNA or DNA and modulating various aspects of nucleic acid metabolism, including splicing, transcription, and translation. ZCCHC18 has been implicated in the fine-tuning of gene expression at the post-transcriptional level, contributing to the regulation of mRNA stability and translation efficiency. These functions are critical for cellular adaptation to environmental changes and for the maintenance of cellular homeostasis. Moreover, ZCCHC18's role extends to the regulation of non-coding RNAs, underscoring its importance in a wide array of cellular processes, from growth and proliferation to differentiation and apoptosis.
The inhibition of ZCCHC18 can occur through several mechanisms that impact its function in RNA metabolism. One primary method of inhibition is the direct interaction with regulatory proteins that modulate its activity or stability. Proteins that interact with ZCCHC18 can alter its ability to bind RNA, thereby inhibiting its regulatory functions. Additionally, post-translational modifications such as phosphorylation, methylation, or ubiquitination can modify the structural integrity or localization of ZCCHC18, affecting its efficiency and capacity to perform its roles within the RNA processing machinery. Another significant aspect of ZCCHC18 inhibition involves genetic regulation; alterations in the expression levels of ZCCHC18 through transcriptional repression or RNA interference can lead to a decrease in its functional protein levels, thereby diminishing its influence on RNA metabolism. These mechanisms collectively ensure that the activity of ZCCHC18 is finely controlled, allowing cells to adjust the expression of various genes in response to developmental cues and external stressors effectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor that can inhibit downstream pathways potentially involving ZCCHC18. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 also targets the PI3K pathway, thus affecting cellular processes that may require ZCCHC18 involvement. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Known for its broad kinase inhibitory properties, Staurosporine may affect kinase-dependent pathways that ZCCHC18 operates in. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor; ZCCHC18 could be indirectly affected if it's a part of Src-related signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an ERK pathway inhibitor and can affect the protein if it's involved in ERK-mediated cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may affect ZCCHC18's function if it's associated with JNK pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor may have an impact if ZCCHC18 operates in a p38 MAPK-dependent pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, MG132 can indirectly affect ZCCHC18 by modulating its degradation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Targets the mTOR pathway, which could be linked to cellular processes involving ZCCHC18. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
As a PP1 and PP2A inhibitor, it may affect ZCCHC18 if it's involved in phosphatase-dependent pathways. | ||||||